148 related articles for article (PubMed ID: 19446554)
1. Structure-function analysis of factor VII activating protease (FSAP): sequence determinants for heparin binding and cellular functions.
Muhl L; Hersemeyer K; Preissner KT; Weimer T; Kanse SM
FEBS Lett; 2009 Jun; 583(12):1994-8. PubMed ID: 19446554
[TBL] [Abstract][Full Text] [Related]
2. High negative charge-to-size ratio in polyphosphates and heparin regulates factor VII-activating protease.
Muhl L; Galuska SP; Oörni K; Hernández-Ruiz L; Andrei-Selmer LC; Geyer R; Preissner KT; Ruiz FA; Kovanen PT; Kanse SM
FEBS J; 2009 Sep; 276(17):4828-39. PubMed ID: 19664058
[TBL] [Abstract][Full Text] [Related]
3. Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP).
Nakazawa F; Kannemeier C; Shibamiya A; Song Y; Tzima E; Schubert U; Koyama T; Niepmann M; Trusheim H; Engelmann B; Preissner KT
Biochem J; 2005 Feb; 385(Pt 3):831-8. PubMed ID: 15654766
[TBL] [Abstract][Full Text] [Related]
4. The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation.
Sedding D; Daniel JM; Muhl L; Hersemeyer K; Brunsch H; Kemkes-Matthes B; Braun-Dullaeus RC; Tillmanns H; Weimer T; Preissner KT; Kanse SM
J Exp Med; 2006 Dec; 203(13):2801-7. PubMed ID: 17145954
[TBL] [Abstract][Full Text] [Related]
5. A positively charged cluster in the epidermal growth factor-like domain of Factor VII-activating protease (FSAP) is essential for polyanion binding.
Altincicek B; Shibamiya A; Trusheim H; Tzima E; Niepmann M; Linder D; Preissner KT; Kanse SM
Biochem J; 2006 Mar; 394(Pt 3):687-92. PubMed ID: 16332249
[TBL] [Abstract][Full Text] [Related]
6. X-ray structures of free and leupeptin-complexed human alphaI-tryptase mutants: indication for an alpha-->beta-tryptase transition.
Rohr KB; Selwood T; Marquardt U; Huber R; Schechter NM; Bode W; Than ME
J Mol Biol; 2006 Mar; 357(1):195-209. PubMed ID: 16414069
[TBL] [Abstract][Full Text] [Related]
7. Factor VII activating protease (FSAP): a novel protease in hemostasis.
Römisch J
Biol Chem; 2002; 383(7-8):1119-24. PubMed ID: 12437095
[TBL] [Abstract][Full Text] [Related]
8. Factor VII activating protease (FSAP): a novel protective factor in liver fibrosis.
Martinez-Palacian A; Kanse SM; Weiskirchen R
Proteomics Clin Appl; 2014 Jun; 8(5-6):438-46. PubMed ID: 24497464
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the enzymatic activity of the serine protease domain of Factor VII activating protease (FSAP).
Nielsen NV; Roedel E; Manna D; Etscheid M; Morth JP; Kanse SM
Sci Rep; 2019 Dec; 9(1):18990. PubMed ID: 31831842
[TBL] [Abstract][Full Text] [Related]
10. Factor VII-activating protease in patients with acute deep venous thrombosis.
Sidelmann JJ; Vitzthum F; Funding E; Münster AM; Gram J; Jespersen J
Thromb Res; 2008; 122(6):848-53. PubMed ID: 18394684
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the substrate specificity of Factor VII activating protease (FSAP) and design of specific and sensitive peptide substrates.
Kara E; Manna D; Løset GÅ; Schneider EL; Craik CS; Kanse S
Thromb Haemost; 2017 Aug; 117(9):1750-1760. PubMed ID: 28726978
[TBL] [Abstract][Full Text] [Related]
12. Structural requirements and mechanism for heparin-dependent activation and tetramerization of human betaI- and betaII-tryptase.
Hallgren J; Lindahl S; Pejler G
J Mol Biol; 2005 Jan; 345(1):129-39. PubMed ID: 15567416
[TBL] [Abstract][Full Text] [Related]
13. Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme.
Kannemeier C; Feussner A; Stöhr HA; Weisse J; Preissner KT; Römisch J
Eur J Biochem; 2001 Jul; 268(13):3789-96. PubMed ID: 11432747
[TBL] [Abstract][Full Text] [Related]
14. Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis.
Kanse SM; Parahuleva M; Muhl L; Kemkes-Matthes B; Sedding D; Preissner KT
Thromb Haemost; 2008 Feb; 99(2):286-9. PubMed ID: 18278176
[TBL] [Abstract][Full Text] [Related]
15. Factor VII activating protease. Single nucleotide polymorphisms light the way.
Kanse SM; Etscheid M
Hamostaseologie; 2011 Aug; 31(3):174-6, 177-8. PubMed ID: 21655671
[TBL] [Abstract][Full Text] [Related]
16. The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB.
Wasmuth HE; Tag CG; Van de Leur E; Hellerbrand C; Mueller T; Berg T; Puhl G; Neuhaus P; Samuel D; Trautwein C; Kanse SM; Weiskirchen R
Hepatology; 2009 Mar; 49(3):775-80. PubMed ID: 19105210
[TBL] [Abstract][Full Text] [Related]
17. Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men.
Borkham-Kamphorst E; Zimmermann HW; Gassler N; Bissels U; Bosio A; Tacke F; Weiskirchen R; Kanse SM
J Hepatol; 2013 Jan; 58(1):104-11. PubMed ID: 22989567
[TBL] [Abstract][Full Text] [Related]
18. The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity.
Etscheid M; Muhl L; Pons D; Jukema JW; König H; Kanse SM
Thromb Res; 2012 Dec; 130(6):935-41. PubMed ID: 22906531
[TBL] [Abstract][Full Text] [Related]
19. Factor seven activating protease (FSAP): does it activate factor VII?
Stavenuiter F; Dienava-Verdoold I; Boon-Spijker MG; Brinkman HJ; Meijer AB; Mertens K
J Thromb Haemost; 2012 May; 10(5):859-66. PubMed ID: 22235940
[TBL] [Abstract][Full Text] [Related]
20. The factor VII-activating protease (FSAP) enhances the activity of bone morphogenetic protein-2 (BMP-2).
Roedel EK; Schwarz E; Kanse SM
J Biol Chem; 2013 Mar; 288(10):7193-203. PubMed ID: 23341458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
